e-learning resources

ERS International Congress, Milan 2017

Browse by day:
Saturday, 09.09.2017
Sunday, 10.09.2017
Monday, 11.09.2017
Tuesday, 12.09.2017
Wednesday, 13.09.2017

  

Sponsored symposia:

Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Cystic fibrosis: treatments and monitoring

Poster Discussion
Chairs: S. Aliberti (Milan, Italy), H. Tiddens (Rotterdam, Netherlands)
Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
K. van de Kant (Maastricht, Netherlands)
Congress or journal article abstract
Congress or journal article abstract
Lumacaftor-Ivacaftor combination therapy in Phe508del homozygous CF patients with end-stage lung disease – preliminary results
C. Murer (Luzern, Switzerland)
Congress or journal article abstract
Congress or journal article abstract
Examining the effects of the Gly551Asp mutation on CT outcomes in children with cystic fibrosis
L. Mok (Perth, WA, Australia)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Nutritional status and pulmonary and respiratory muscle function in children and young people with cystic fibrosis
N. Papalexopoulou (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Respiratory rate in infants with Cystic Fibrosis and healthy controls throughout the first year of life.
I. Korten (Bern, Switzerland)
Congress or journal article abstract
Congress or journal article abstract
Dynamic hyperinflation and daily physical activity in adults with cystic fibrosis
D. Savi (Cantalupo in Sabina, Rieti, Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Observational study of respiratory tract microflora in CF patients over a 15-year period
V. Sherman (Moscow, Russian Federation)
Congress or journal article abstract
Congress or journal article abstract
Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
A. Faniyi (BELFAST, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Does Pseudomonas status affect exercise capacity in CF?
E. Hatziagorou (Thessaloniki, Greece)
Congress or journal article abstract
Congress or journal article abstract
Functional magnetic resonance imaging and lung function tests in cystic fibrosis
S. Nyilas (Bern, Switzerland)
Congress or journal article abstract
Congress or journal article abstract
LCI in young children with CF – N2 or SF6?
M. Stahl (Heidelberg, Germany)
Congress or journal article abstract
Congress or journal article abstract
Potential utility of the N2 VC SBW test in cystic fibrosis (CF)
S. Kjellberg (Skara, Sweden)
Congress or journal article abstract
Congress or journal article abstract
Inter-test reproducibility of the lung clearance index measured by multiple breath washout
E. Oude Engberink (Nijmegen, Netherlands)
Congress or journal article abstract
Congress or journal article abstract
Real-time exhaled breath analysis identifies altered metabolic signature in cystic fibrosis
T. Gaisl (Zürich, Switzerland)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster